Search research articles
Contact Us
Filters
Showing results (91-100 of 328) with videos related to
Page
of 33
Sort By:
Seminars in Ophthalmology
|
December 14, 2004
Optic neuropathy due to anaplastic large cell lymphoma
James G Howard, Andrew G Lee, Mark Garwood, et al.
Pathologie-Biologie
|
May 1, 1991
Rapid antimicrobial susceptibility testing of gram-negative bacilli using Baxter MicroScan rapid fluorogenic panels and autoSCAN-W/A
J H Godsey, S Bascomb, T Bonnette, et al.
Journal of Managed Care Pharmacy : JMCP
|
November 14, 2003
Days of prophylactic filgrastim use to reduce febrile neutropenia in patients with non-Hodgkin's lymphoma treated with chemotherapy
Shane D Scott, Elizabeth A Chrischilles, Brian K Link, et al.
Leukemia & Lymphoma
|
October 21, 2005
Long-term update of a phase II study of rituximab in combination with CHOP chemotherapy in patients with previously untreated, aggressive non-Hodgkin's lymphoma
J M Vose, B K Link, M L Grossbard, et al.
Leukemia
|
March 11, 2005
Good prognosis cytogenetics in B-cell chronic lymphocytic leukemia is associated in vitro with low susceptibility to apoptosis and enhanced immunogenicity
B Jahrsdörfer, J E Wooldridge, S E Blackwell, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 1, 1986
The effect of androgens on the pulsatile release and the twenty-four-hour mean concentration of growth hormone in peripubertal males
K Link, R M Blizzard, W S Evans, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 17, 2016
Complement-Regulatory Proteins CFHR1 and CFHR3 and Patient Response to Anti-CD20 Monoclonal Antibody Therapy
Laura M Rogers, Sarah L Mott, Brian J Smith, et al.
Vaccine
|
November 29, 2024
A Brighton collaboration standardized template with key considerations for a benefit/risk assessment for a viral vector vaccine based on a non-replicating modified vaccinia virus Ankara viral vector
Ellen K Link, Alina Tscherne, Gerd Sutter, et al.
JAAD Case Reports
|
October 27, 2018
Primary diffuse large B cell lymphoma of the vulva-Two new cases of a rare entity and review of the literature
Alice L Ye, Melissa S Willis, Brian K Link, et al.
Journal of the American Academy of Dermatology
|
October 5, 2010
Phase I trial of a Toll-like receptor 9 agonist, PF-3512676 (CPG 7909), in patients with treatment-refractory, cutaneous T-cell lymphoma
Youn H Kim, Michael Girardi, Madeleine Duvic, et al.
Page
of 33
Search research articles
Search
Showing results (91-100 of 328) with videos related to
Sort By:
Page
of 33
Seminars in Ophthalmology
|
December 14, 2004
Optic neuropathy due to anaplastic large cell lymphoma
James G Howard, Andrew G Lee, Mark Garwood, et al.
Pathologie-Biologie
|
May 1, 1991
Rapid antimicrobial susceptibility testing of gram-negative bacilli using Baxter MicroScan rapid fluorogenic panels and autoSCAN-W/A
J H Godsey, S Bascomb, T Bonnette, et al.
Journal of Managed Care Pharmacy : JMCP
|
November 14, 2003
Days of prophylactic filgrastim use to reduce febrile neutropenia in patients with non-Hodgkin's lymphoma treated with chemotherapy
Shane D Scott, Elizabeth A Chrischilles, Brian K Link, et al.
Leukemia & Lymphoma
|
October 21, 2005
Long-term update of a phase II study of rituximab in combination with CHOP chemotherapy in patients with previously untreated, aggressive non-Hodgkin's lymphoma
J M Vose, B K Link, M L Grossbard, et al.
Leukemia
|
March 11, 2005
Good prognosis cytogenetics in B-cell chronic lymphocytic leukemia is associated in vitro with low susceptibility to apoptosis and enhanced immunogenicity
B Jahrsdörfer, J E Wooldridge, S E Blackwell, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 1, 1986
The effect of androgens on the pulsatile release and the twenty-four-hour mean concentration of growth hormone in peripubertal males
K Link, R M Blizzard, W S Evans, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 17, 2016
Complement-Regulatory Proteins CFHR1 and CFHR3 and Patient Response to Anti-CD20 Monoclonal Antibody Therapy
Laura M Rogers, Sarah L Mott, Brian J Smith, et al.
Vaccine
|
November 29, 2024
A Brighton collaboration standardized template with key considerations for a benefit/risk assessment for a viral vector vaccine based on a non-replicating modified vaccinia virus Ankara viral vector
Ellen K Link, Alina Tscherne, Gerd Sutter, et al.
JAAD Case Reports
|
October 27, 2018
Primary diffuse large B cell lymphoma of the vulva-Two new cases of a rare entity and review of the literature
Alice L Ye, Melissa S Willis, Brian K Link, et al.
Journal of the American Academy of Dermatology
|
October 5, 2010
Phase I trial of a Toll-like receptor 9 agonist, PF-3512676 (CPG 7909), in patients with treatment-refractory, cutaneous T-cell lymphoma
Youn H Kim, Michael Girardi, Madeleine Duvic, et al.
Page
of 33